The Wake Forest is for regenerative medicine (WFIRM) is a well-known institute for science.
The Wake Forest is for Regenerative Medicine (WFIRM) is a well-known institute for science. They use 3D printing technologies with nanotechnology and gene editing for biomanufacturing tissue, cell therapies, diagnostics, drug discovery.
According to Anthony Atala, MD, Chair, and Wake Forest School of Medicine Institute Director, “We have many challenges to meet, but are optimistic about the ability of the field to have a significant impact on human health. We believe regenerative medicine promises to be one of the most pervasive influences on public health in the modern era.”
According to Professor Georg Nickenig, lead investigator of the study and chair of Internal Medicine and Polyclinic II at the University of Bonn, Germany, presented findings. Data show a TR reduction of at least one grade in 87 percent of patients with symptomatic or greater TR and improvements in quality-of-life, “The TriClip is a version of the MitraClip used for transcatheter mitral valve repair (TMVR) to resolve mitral regurgitation. A post hoc registry analysis of MitraClip use for TR has indicated TR reduction and improved clinical outcomes out to one year. Treatment for TR is currently limited to the use of diuretics and high-risk surgical procedures. Nickenig said minimally invasive catheter-based procedures (such as TriClip) may reduce TR with low procedural risk.”